Provenance
Created by SPS, the British Association for Sexual Health and HIV (BASHH), the British HIV Association and the support of specialist stakeholders working within clinical practice for sexual health services.
Template versions available
Version 3.0 of this PGD template, valid from July 2026, has been published to allow organisations to undertake local governance processes in a timely manner.
Version 2.1 of this PGD template remains currently valid and will be removed from this page on its expiry (30th June 2026).
PGD template attachment
The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).
More sexual health PGD templates
- Ceftriaxone intramuscular injection for Neisseria gonorrhoeae
- Doxycycline post exposure prophylaxis (doxyPEP)
- Emtricitabine/tenofovir and raltegravir tablets for HIV PEP
- Imiquimod 5% w/w cream for anogenital warts
- Podophyllotoxin (topical) for external anogenital warts
- Emtricitabine and tenofovir alafenamide (TAF) tablets as PrEP
- Emtricitabine and tenofovir disoproxil (TD) tablets as PrEP
- Doxycycline for use within sexual health services
- Azithromycin (oral) for use within sexual health services
- Aciclovir (oral) for genital HSV infection
- Clotrimazole cream for candidiasis and candidal balanoposthitis
- Clotrimazole pessaries for candidiasis
- Fluconazole 150mg capsules for candidiasis
All PGD templates
National PGD, protocol and written instructions templates
National templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
Update history
- Republished
- Version 3.0 published
- Version 2.1 of the PGD template published to reflect SPC updates
- V1 template removed as expired.
- Title, URL and summary amended.
- New V2.0 PGD template added
- Updated PGD template attached to reflect updated BASHH TV guidance
- Published